Jacobson Pharma Corporation Limited (HKG:2633)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.070
0.00 (0.00%)
Jul 31, 2026, 3:57 PM HKT

HKG:2633 Cash Flow Statement

Millions HKD. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
301.62300.83266.97251.04177.67
Depreciation & Amortization
153.79143.87141.82148.65187.91
Other Amortization
----4.69
Loss (Gain) From Sale of Assets
0.184.10.063.55-0.25
Asset Writedown & Restructuring Costs
7.7830.327.43--5.55
Loss (Gain) From Sale of Investments
-0.240.84-1.62-8.9-3.3
Loss (Gain) on Equity Investments
-4.68-0.40.443.563.77
Stock-Based Compensation
17.9215.3519.3719.14-
Other Operating Activities
2.2535.93-15.52142.46
Change in Accounts Receivable
-36.4238.92-68.2723.78-62.79
Change in Inventory
-39.3-15.02-9.3-53.4541.63
Change in Accounts Payable
-74.51-27.9863.85116.520.72
Operating Cash Flow
328.39526.78484.36630.09406.94
Operating Cash Flow Growth
-37.66%8.76%-23.13%54.84%-0.57%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-136.19-248.38-129.51-63-63.86
Sale of Property, Plant & Equipment
0.241.120.240.520.08
Cash Acquisitions
---0.91-11.43
Investment in Securities
-96.75-63.31144.45-91.5622.46
Other Investing Activities
8.3212.8228.1718.152.82
Investing Cash Flow
-224.38-297.7643.34-134.98-49.94

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Long-Term Debt Issued
8575308521,560967
Total Debt Issued
8575308521,560967
Long-Term Debt Repaid
-743.94-554.28-1,610-1,388-1,247
Total Debt Repaid
-743.94-554.28-1,610-1,388-1,247
Net Debt Issued (Repaid)
113.07-24.28-757.52172.3-279.52
Issuance of Common Stock
--38.9--
Repurchase of Common Stock
-9.55-6.08-7.69-32.42-
Common Dividends Paid
-314.98-59.57-93.6-104.03-51.72
Other Financing Activities
-30.71-41.37-233.34-72.45-26.65
Financing Cash Flow
-242.18-131.3-1,053-36.6-357.89

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
-1.02-0.621.07-0.74-0.81
Net Cash Flow
-139.1997.11-524.48457.77-1.7

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
192.2278.39354.85567.09343.08
Free Cash Flow Growth
-30.96%-21.55%-37.43%65.29%-0.82%
Free Cash Flow Margin
12.25%17.66%24.18%44.74%21.50%
Free Cash Flow Per Share
0.100.140.180.300.18
Levered Free Cash Flow
102.03231.07260.88345.79285.35
Unlevered Free Cash Flow
121.22256.93310.07384.17301.41

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
3.412.471.681.591.48
Cash Income Tax Paid
81.0961.3756.9347.633.98
Change in Working Capital
-150.22-4.08-13.7386.83-0.44